Abstract | BACKGROUND: Radioguided-surgery has been recently proposed in patients with clinically occult breast lesions. This study aimed to evaluate the feasibility of correctly locating and eradicating, by a single intralesional injection of a radiotracer, any breast lesion and, in the case of malignancy, to perform simultaneous sentinel lymph node (SLN) biopsy procedure. PATIENTS AND METHODS: RESULTS: Scintigraphic images clearly identified the lesions in all patients while SLN/s were evident in 88% of them. At surgery all the breast lesions were easily radiolocalized and eradicated with minimum surgical trauma and, for those patients with invasive carcinomas, the SLN technique was performed in 86% of them. No skip metastases were found. CONCLUSION: A single intralesional administration of radiotracer is an easy and reliable procedure to simultaneously locate and remove both the non-palpable breast lesion and the SLN when primary malignancy was intraoperatively confirmed.
|
Authors | O Buonomo, A Cabassi, F Guadagni, A Piazza, A Felici, R Piccirillo, G P Atzei, C Cipriani, S Schiaroli, S Mariotti, M N Guazzaroni, E Cossu, G Simonetti, E Pernazza, C U Casciani, M Roselli |
Journal | Anticancer research
(Anticancer Res)
2001 May-Jun
Vol. 21
Issue 3C
Pg. 2091-7
ISSN: 0250-7005 [Print] Greece |
PMID | 11501831
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Radiopharmaceuticals
- Technetium Tc 99m Aggregated Albumin
- technetium Tc 99m nanocolloid
|
Topics |
- Adult
- Aged
- Breast Neoplasms
(diagnostic imaging, surgery)
- Female
- Humans
- Injections, Intralesional
- Lymph Nodes
(surgery)
- Mastectomy, Segmental
(methods)
- Middle Aged
- Radionuclide Imaging
- Radiopharmaceuticals
(therapeutic use)
- Sentinel Lymph Node Biopsy
- Technetium Tc 99m Aggregated Albumin
(therapeutic use)
|